In addition, the increase in the endogenous ligand ProSAAS, seen in circulating CSF of fibromyalgia patients, is likely a consequence of adaptations toward restoring GPR171 signaling as we have observed a decrease in brain-specific GPR171 receptor expression in males with neuropathic pain (18). This evidence concerns the gene GPR171 and fibromyalgia.